Use of an avirulent live Salmonella Choleraesuis vaccine to reduce the prevalence of Salmonella carrier pigs at slaughter by Schwarz, P. et al.
November 19, 2011 | Veterinary Record
Papers
Papers
Use of an avirulent live Salmonella Choleraesuis 
vaccine to reduce the prevalence 
of Salmonella carrier pigs at slaughter
P. Schwarz, J. D. Kich, J. Kolb, M. Cardoso
This study evaluated the use of an avirulent live Salmonella Choleraesuis vaccine to reduce 
the seroprevalence and number of Salmonella carrier pigs at slaughter. Seven batches of 500 
pigs were included in each of the two study groups: the vaccinated group (VG) that was orally 
vaccinated and the control group (CG) that received a placebo on the first day of life. The 
groups were managed in a three-site system and followed up from birth to slaughter. Blood 
samples (n=378) were collected from each VG and CG to monitor the on-farm seroprevalence 
in both groups. Mesenteric lymph nodes and blood from animals (n=390) belonging to 
each group were collected at slaughter. At the first day of life, the seroprevalence in control 
batches ranged from 77.9 to 96.3 per cent, while in vaccinated batches, it ranged from 66.6 
to 92.6 per cent. At weaning (21 days of age), the number of seropositives decreased in both 
groups (mean of 12 and 3.7 per cent for CG and VG, respectively). At slaughter, batches of 
VG had a significantly (P<0.0001) lower seroprevalence (46.6±5 per cent) and isolation of 
Salmonella from lymph nodes (33.1±5 per cent) compared with CG batches (79.7±4 per cent 
and 59.5±5 per cent, respectively). The results indicate that administration of a Salmonella 
choleraesuis-attenuated vaccine on the first day of life decreases Salmonella isolation and 
seroprevalence in pigs at slaughter.
Salmonella enterica is one of the major foodborne pathogens transmit-
ted by pork, and a decrease in the number of carrier pigs at slaughter 
is considered the first step in achieving Salmonella-free pork products 
(Berends and others 1996). Salmonella control has mainly been based 
on the measures to improve postharvest hygiene and good manage-
ment practices on farms (Mousing and others 1997, Alban and others 
2002). In Denmark, these measures led to a reduction in the number 
of herds with high Salmonella seroprevalence, as well as in the number 
of human salmonellosis cases associated with the consumption of 
pork (Alban and Stärk 2005); however, the costs estimated for this 
programme were considered high (Goldbach and Alban 2006).
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Different strategies have been investigated to control Salmonella 
in the pig industry including the addition of organic acid to feed 
(Creuss and others 2007) or water (De Busser and others 2009) and 
the administration of probiotics (Casey and others 2007) or prebiotics 
(Martín-Peláez and others 2010) to the pigs. Although the addition of 
probiotics and acids to the feed has been shown to decrease the fae-
cal excretion of Salmonella (Casey and others 2007, Creuss and others 
2007), their effects may be restricted to a specific age group or their use 
might only be a strategic measure for the preslaughter.
Vaccination may be a viable approach for shortening the time 
required to decrease the number of herds with a high infection rate via 
the increase of resistance to Salmonella in susceptible pigs (Haesebrouck 
and others 2004, Boyen and others 2008). A long-lasting immuni-
ty to infection relies upon the development of T - and B-cell-specific 
immunity (Mastroeni and others 2000). Killed Salmonella whole-cell 
vaccines have been used in animals with variable results, probably due 
to their poor ability to induce cell-mediated immunity in vaccinated 
animals (Xu and others 1993, Yamane and others 2000, Davies and 
Breslin 2003). On the other hand, attenuated live vaccine strains have 
been shown to offer better protection against Salmonella infection due 
to the cellular immune response and the induction of mucosal IgA 
production (Haesebrouck and others 2004). Live vaccine strains can 
be divided into three types (Mastroeni and others 2000): strains that 
are attenuated without the attenuation being localised or character-
ised; strains with a mutation in genes that are important for bacte-
rial metabolism, such as aroA (Lumsden and Wilkie 1992); strains in 
which specific virulence genes are removed, for example, the spv genes 
located on the Salmonella virulence plasmid (Kramer and others 1992) 
or strains with defined knockout mutation (Boyen and others 2009).
The SC-54 attenuated strain of S enterica serovar Cholearaesuis 
variety Kurzendorf was obtained after repeated passages of a viru-
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At 14 days of age, the piglets started to receive feed with zinc oxide 
and colistin added to it. Animals from VG and CG were weaned at 
21 days of life and housed in nursery units with similar management 
practices and health status. The nursery farms typically comprised 
one barn with two rooms, housing a mean of 1000 pigs. Each room 
had approximately 25 pens with 20 pigs per pen. The nursery facili-
ties comprised a partially slatted floor and a solid partition, nipple 
drinkers and common feeders. The farms were submitted to all in/all 
out (AIAO) management by room, with an empty period of four days 
after cleaning and disinfection with quaternary ammonium com-
pounds. The diets were supplemented with colistin, and two ten-day 
pulses of amoxicillin and florfenicol were administered to the animals 
on the first and third week after housing.
At 56 days of age, VG and CG were housed in finishing farms 
comprising one barn with a single room. The finishing farms housed 
between 300 and 450 pigs in 20 to 30 pens (15 pigs per pen), with 
partially slatted floors, solid partition, nipple drinkers and common 
feeders. These farms were also subjected to AIAO management by 
farm, with an empty period of seven days after cleaning and disinfec-
tion with quaternary ammonium compounds. A total of 13 finishing 
farms were needed for the placement of each experimental group; the 
seven nursery barns filled 13 finishing barns. Three ten-day antimicro-
bial pulses were administrated to the finishing pigs: tiamulin/doxycy-
cline (first week after placement), florfenicol (eighth week after place-
ment) and tiamulin/doxycycline (12th week after placement).
At 150 days of age, the pigs were transported to the same slaughter-
house in trailers that were cleaned and disinfected daily with quaternary 
ammonium compounds. The length of transportation was up to three 
hours and the holding period between five and six hours. The holding 
pens were cleaned and disinfected with peracetic acid before placement 
of the pigs. A total of 13 batches (one per finishing farm) of VG and CG 
were slaughtered. Slaughtering was conducted over seven different days 
and up to two batches each of VG and CG were slaughtered each day. 
The slaughter batches were kept separated in the holding pens.
Sample collection
At each site (farrowing, nursery and finishing), sampling for serolo-
gy and bacteriological cultures was conducted in all batches in order 
to monitor the exposure to Salmonella and the seroprevalence in VG 
and CG.
In each batch, blood from 54 piglets in VG and 54 in CG was 
sampled at the first, 21st and 49th day of age. This sample size was 
sufficient (95 per cent confidence interval) to detect at least one posi-
tive sample when considering a 5 per cent minimum expected preva-
lence in the herd (T oma and others 1999). These sampling times were 
chosen in order to estimate the seroprevalence resulting from passive 
immunity before vaccination (day 1), the decrease in the passive anti-
body titer (day 21) and seroconversion in the nursery period (day 49).
Before the housing in the nursery, environmental samples were 
collected to monitor residual Salmonella contamination. One drag swab 
was taken from the solid area of the floor in 10 pens per room and 
processed in pools of five swabs. At 49 days of age (nursery) and at 143 
days of age (finishing), faecal samples were collected from 10 animals 
in each batch in order to detect faecal shedding before being transport-
ed to the finishing farms and the slaughterhouse, respectively. In each 
sampling event, five pens (four on the corners and one in the middle 
of the barn) were chosen, and two animals were sampled in each pen. 
Faecal samples were processed in pools of two samples, making a total 
of five pools per batch in each group (VG and CG).
At slaughter, blood samples and mesenteric lymph nodes were 
taken from 30 animals from the 13 batches of both VG and CG. 
This sample size allowed the estimation of herd prevalence, given an 
expected prevalence of 65 per cent (Kich and others 2005) and a rela-
tive precision of 15 per cent (T oma and others 1999).
Sample processing
Serum samples were submitted to an indirect ELISA-LPS test to detect 
IgG anti-Salmonella antibodies. The test is based on somatic antigens 
1, 4, 5 and 12 of Salmonella, with an optical density cut-off point of 
0.169. At this cut-off point, the test has a sensitivity of 0.92 and a spe-
cificity of 1.0 (Kich and others 2007). Pooled faeces (25 g), drag swabs 
lent strain in swine neutrophils, resulting in the loss of the spv gene 
from the virulence plasmid (Kramer and others 1992, Roof and others 
1992). Trials conducted on artificially inoculated mice and pigs dem-
onstrated that the vaccine derived from SC-54 strain is safe and able to 
protect animals from infection and clinical disease (Kramer and others 
1992, Baum and others 1997). Moreover, the use of this vaccine to 
control Salmonella carriers yielded promising results in trials conducted 
with artificially infected pigs (Letellier and others 2001), calves (Fox 
and others 1997) and dairy cows (House and others 2001).
In Brazil, studies have shown a high prevalence of carrier pigs at 
slaughter (Bessa and others 2004, Schwarz and others 2009), high-
lighting the fact that efficient and cost-effective measures, which can 
be associated with good management practices in farms, are needed 
to achieve Salmonella control. Thus, this study evaluated the use of the 
vaccine produced with the SC-54 strain in a herd with a high Salmonella 
prevalence with the aim of reducing the number of Salmonella carriers 
at slaughter.
Materials and methods
Location of the trial
The trial was conducted in a three-site vertical integration company 
with a history of a high prevalence of pigs carrying S enterica in the 
mesenteric lymph nodes (85 per cent) and a high rate of seroposi-
tives (77.8 per cent). The most prevalent serovars in this herd were 
S Brandenburg, S T yphimurium and S Agona (Schwarz and others 
2009).
Vaccine
The animals were vaccinated with the attenuated live vaccine 
EnterisolSC-54 (Boehringer Ingelheim Vetmedica GmbH) containing 
the Salmonella Choleraesuis variety Kurzendorf SC-54 strain attenuated 
via several passages in pig neutrophils (Roof and others 1992).
Study design and management of the animals
A controlled, blinded clinical trial was designed to assess the efficacy 
of EnterisolSC-54 orally administered to piglets. The experiment was 
started in the breeding site, located in a farm with a 1000 sow inven-
tory housed in two barns. The facilities and management practices in 
both barns were similar. Sows were maintained in individual crates 
in all phases of production. Breeding and gestation rooms were man-
aged with a continuous flow of sows. Salmonella seroprevalence in sows 
housed in this farm was determined before the start of the trial and a 
similar seroprevalence (98 to 100 per cent) was observed in both barns.
Since a live vaccine was tested, the vaccinated group (VG) and con-
trol groups (CG) could not be housed in the same barn; thus, one sow 
barn was randomly selected for performing the vaccination, while the 
other barn housed the controls. For the same reason, the nursery and 
finishing units exclusively received pigs from either the VG or CG. 
Pigs not entered into the study were co-mingled with experimental 
pigs from both VG and CG. Piglets born to sows housed in one barn 
were VG, while piglets born in the same week to sows housed in the 
other barn constituted the CG. Each group (VG and CG) included seven 
batches of 500 piglets born within a one-week interval over seven con-
secutive weeks, making a total of 3500 pigs in VG and CG. Both groups 
were managed according to the company’s standard practices in all three 
sites and followed up side by side from birth to slaughter. Piglets in all 
sites received chlorinated water, which was periodically monitored for 
quality by the company. Pelleted diets with a composition and nutrient 
contents in compliance with the recommendations for each stage were 
manufactured in the company’s feed mill. The diet in both groups was 
not supplemented with acids, probiotics or prebiotics.
Piglets in VG received 2 ml of the vaccine orally on the first day 
of life and iron dextran was routinely administered to animals of that 
age. They were notched in their right ear and did not receive antimi-
crobials until three days after vaccination. Animals that required treat-
ment with antimicrobial drugs in the first week of life were excluded 
from the trial. Between five and six piglets were excluded from each 
vaccinated batch. The CG included pigs of the same age that received 
the same management, except for the vaccine. They were identified 
with a notch in the left ear. The employees at the farms and at the 
laboratory were blind to the treatment groups (VG or CG).
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and individual lymph node (25 g) samples were processed using a 
Salmonella isolation protocol comprised of pre-enrichment in 1 per cent 
buffered peptoned water, selective enrichment (tetrathionate broth and 
Rappaport-Vassiliadis broth; Merck; 42ºC, 24 hours) and isolation on 
solid medium (xylose-lysine-tergitol 4 agar and Brilliant Green-phenol 
red-lactose-sucrose agar; Bencton-Dickson and Company; 37ºC, 
24 hours), as previously described (ISO6579). Isolates identified as 
Salmonella species were shipped to Fundação Instituto Oswaldo Cruz 
for serotyping.
Statistical analysis
All statistical analyses were performed using commercial software 
(SAS 9.1.3; 2009). Logistic regression was used to test the relationship 
between vaccination and seroprevalence or Salmonella isolation from 
the mesenteric lymph nodes at slaughter. Overdispersion was correct-
ed by Williams’ method. p-Values <0.05 were considered significant. 
Spearman’s correlation was calculated between frequency of Salmonella 
presence in lymph nodes and the batch serology at slaughter.
Results
Seroprevalences ranging from 77.9 to 96.3 per cent were found in 
batches of one-day-old piglets belonging to the CG, while in vacci-
nated batches frequencies of seropositive piglets varied between 66.6 
and 92.6 per cent. On day 21, a prominent decrease in the frequency 
of seropositives was observed in the batches of both groups (T able 1). 
No statistical difference between groups was observed in seropreva-
lence (P>0.05).
Five nursery facilities had environmental samples that were posi-
tive for Salmonella before the allocation of pigs, and both groups were 
exposed to a similar challenge (two of four positive farms in VG and 
three of four in CG). At 49 days of age, only one batch of VG had posi-
tive faecal samples. This group was housed in one of the farms that 
was positive on environmental sampling. All sampled animals from 
VG were serologically negative on this sampling event, while three 
batches of CG presented seropositive pigs in frequencies ranging from 
3.7 to 5.5 per cent.
At the finishing phase (143-day-old pigs), most batches belonging 
to both experimental groups had at least one Salmonella-positive faecal 
pool. However, the number of positive pools was lower in batches of 
VG (median=1) compared with CG (median=3).
At slaughter, the isolation of Salmonella from mesenteric lymph 
nodes in VG (129/390; mean=33.1 per cent; IC95=28.1 to 38.1 per 
cent) was significantly (P<0.000l) less frequent than in CG (232/390; 
mean=59.5 per cent; IC95=54.5 to 64.5 per cent). The Salmonella 
serovars identified in the samples from both groups were similar, and 
S Agona (33 per cent), S Panama (27 per cent), S Ohio (11 per cent), 
S Schwarzengrund (11 per cent) and S T yphimurium (5 per cent) 
were the most prevalent. The seroprevalence at slaughter was also 
significantly (P<0.0001) lower in VG (174/390; mean=44.6 per-
cent; IC95=39.6 to 49.6 per cent) than in CG (311/390; mean=79.7 
per cent; IC95=74.7 to 83.7 per cent). Vaccinated batches therefore 
had a lower chance of having pigs at slaughter that were positive for 
Salmonella isolation from lymph nodes (OR=0.33; CI95=0.19 to 
0.57) and in ELISA testing (OR=0.20; CI95=0.09 to 0.42).
Discussion
This study demonstrated that the vaccine based on the attenuated 
strain SC-54 was able to significantly reduce the seroprevalence and 
the number of Salmonella-carrier pigs in mesenteric lymph nodes at 
slaughter. These results agree with those of previous studies where a 
reduction in the number of positive animals was found at slaughter, 
even though they adopted different vaccination protocols and evalua-
tion parameters. The SC-45 strain was tested in previous studies that 
evaluated the administration of the vaccine via drinking water to pigs 
allocated in finishing farms (Baum and others 1997, Kolb and others 
2002). In one trial, a statistically significant reduction in Salmonella 
isolation was achieved for serogroups B and C1 but not for serogroups 
C2 or E (Baum and others 1997). In the second trial, a significant 
(p=0.02) reduction in the frequency of Salmonella isolated from car-
casses in the VG was observed in a herd that previously presented a 
prevalence of 26.2 per cent positive carcasses (Kolb and others 2003).
In our study, oral administration of the SC-54 strain vaccine to 
one-day-old piglets was evaluated in a vertically integrated system 
with a history of high (>70 per cent) seroprevalence and Salmonella 
isolation at slaughter. Vaccinated and control batches, following 
a longitudinal study, showed a similar pattern of transmission and 
seroconversion. One-day-old piglets of both groups presented a high 
seroprevalence, possibly caused by the transfer of maternal antibodies, 
as described by Funk and others (2001) and Chiu and others (2006). 
In this sense, piglets in both groups had been delivered by seroposi-
tive sows and both presented antibody concentrations that gradually 
decreased from birth until the 21st day of age.
The disappearance of colostral antibodies coincided with transfer to 
the nursery, where stress factors are responsible for increasing suscepti-
bility to infection in pigs (Funk and others 2001, Fosse and others 2009). 
In addition, the residual environmental contamination of the nursery 
facilities observed in the study and the co-mingling with non-vaccinated 
pigs could have contributed to Salmonella transmission. Despite this, after 
28 days (49-day-old pigs) in the nursery, only three batches were detected 
with a (low) prevalence of seropositive pigs (2 per cent, IC95=0 to 6 per 
cent) and only one cohort from the VG group was shedding Salmonella, 
indicating that most of the pigs were either negative for Salmonella or 
the animals were still in the initial stages of infection. At the finishing 
site, the pigs started to shed Salmonella in their faeces, in line with the 
amplification in the number of infected animals often observed at this 
stage (Funk and others 2001, Lo Fo Wong and others 2004). However, 
the VG showed a lower number of positive faecal pools, which may 
have resulted from a lower number of infected animals due to the pro-
tection conferred by vaccination. Although a poor correlation between 
individual Salmonella ELISA tests and bacteriology on an individual pig 
basis has been reported (Christensen and others 1999, Davies and others 
2003), the seroprevalence at slaughter has demonstrated a strong correla-
tion with the presence of Salmonella in caecal contents and on the carcass 
surface in pig batches (Sørensen and others 2004). Thus, programmes to 
control Salmonella have aimed to reduce seroprevalence in herds to levels 
below 40 per cent, as well as the eradication of herds with seroprevalence 
above 70 per cent in order to decrease the hazard of carcass contamina-
tion at slaughter (Mousing and others 1997, Alban and Stärk 2005). In 
our study, all batches vaccinated with the SC-54 strain presented sero-
prevalences below 70 per cent, whereas the control cohorts presented 
a significantly (P<0.0001) higher number of seropositive pigs. A mod-
erate correlation (r=0.506) was observed between seroprevalence and 
Salmonella isolation from mesenteric lymph nodes, and the VG showed a 
significant reduction (P<0.0001) in the frequency of Salmonella isolation 
from mesenteric lymph nodes, demonstrating that the vaccination had 
a protection effect. Veterinary vaccine challenge studies should provide 
evidence for vaccine efficacy, presenting internal controls and replicating 
field conditions (Denagamage and others 2007). The authors conducted 
a clinical trial that followed up seven batches of vaccinated pigs and a 
similar group of control pigs from birth to slaughter in a multiple-site 
system, which had a history of high Salmonella prevalence. This herd 
presented a significant reduction in seroprevalence and the number of 
Salmonella lymph node carriers in vaccinated batches at slaughter, which 
supports studies that proposed the use of vaccines for the control of 
Salmonella infection (Maes and others 2001, Haesenbrouck and others 
2004, Boyen and others 2008). Live-attenuated vaccines are more suit-
able for induction of cell-mediated immunity required for an effective 
protection against facultative intracellular bacteria, such as Salmonella spe-
cies. However, mucosal and serum antibodies against somatic antigens 
also play a role in host immunity (Haesenbrouck and others 2004), and 
a low level of cross-protection is observed between antibodies induced 
by different Salmonella serovars (Wallis 2001). Therefore, the further 
TABLE 1: Seroprevalence in vaccinated and control groups at birth 
(first day of life), at weaning (21 days of age) and at nursery 
(49 days of age)
Seropositives % (95% CI)
Birth Weaning Nursery
Control group 89.1 (85.1-93.1) 12.0 (9.0-15.0) 2.0 (0-6.0)
Vaccinated group 82.2 (78.2-86.2)   3.7 (0-8.7) 0
VetRecord-2011-100218.indd   Sec1:3 VetRecord-2011-100218.indd   Sec1:3 11/17/2011   2:00:50 PM 11/17/2011   2:00:50 PMVeterinary Record | November 19, 2011
Papers
  development of a vaccine including an attenuated S T yphimurium strain 
may be able to induce an even better protection in pigs.
Another issue about the use of vaccines has been the induction of 
antibodies that interfere with the serological tests adopted by moni-
toring programs (Leyman and others 2011). In the present study, no 
  seroconversion after vaccination was noticed in the ELISA test based 
on somatic antigens 1, 4, 5 and 12 of Salmonella. It may be related 
to the fact that somatic antigens of S Choleraesius (O:6, 7) are not 
included in the adopted test. However, low frequencies of seroposi-
tive pigs have also been reported after the administration of the SC-54 
strain vaccine, when tests that included somatic antigens 6 and 7 were 
used (Maes and others 2001).
In conclusion, in herds with a high prevalence of Salmonella, vacci-
nation with the SC-54 strain can be considered as an additional man-
agement tool to reduce the number of carriers in a shorter period of 
time, even though changes in management and the correction of risk 
factors remain essential for achieving the target of a low prevalence 
level in Salmonella control programmes.
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